References
- Donadio JV, Grande JP. IgA nephropathy. N Engl J Med 2002; 347:738-48. https://doi.org/10.1056/NEJMra020109
- D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000;36:227-37. https://doi.org/10.1053/ajkd.2000.8966
- Katafuchi R, Vamvakas E, Neelakantappa K, Baldwin DS, Gallo GR. Microvascular disease and the progression of IgA nephropathy. Am J Kidney Dis 1990;15:72-9. https://doi.org/10.1016/S0272-6386(12)80595-6
- Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006;65: 936-41.
- Koutkia P, Mylonakis E, Rounds S, Erickson A. Leucocytoclastic vasculitis: an update for the clinician. Scand J Rheumatol 2001;30:315-22. https://doi.org/10.1080/030097401317148499
- Davin JC, Weening JJ. Henoch-Schönlein purpura nephritis: an update. Eur J Pediatr 2001;160:689-95.
- Lee TH, Lee EY, Cho YS, Yoo B, Moon HB, Lee CK. Concurrent occurrence of chylothorax and chylous ascites in a patient with Henoch-Schonlein purpura. Scand J Rheumatol 2003; 32:378-9. https://doi.org/10.1080/03009740410005070
- Kaku Y, Nohara K, Honda S. Renal involvement in Henoch-Schonlein purpura: a multivariate analysis of prognostic factors. Kidney Int 1998;53:1755-9. https://doi.org/10.1046/j.1523-1755.1998.00915.x
- Ronkainen J, Ala-Houhala M, Huttunen NP, Jahnukainen T, Koskimies O, Ormälä T, et al. Outcome of Henoch-Schoenlein nephritis with nephrotic-range proteinuria. Clin Nephrol 2003;60:80-4. https://doi.org/10.5414/CNP60080
- Counahan R, Winterborn MH, White RHR, Heaton JM, Meadow SR, Bluett NH, et al. Prognosis of Henoch-Schönlein nephritis in children. Br Med J 1977;2:11-4 https://doi.org/10.1136/bmj.2.6078.11
- Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009;76:534-45. https://doi.org/10.1038/ki.2009.243
- Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 2009;76:546-56. https://doi.org/10.1038/ki.2009.168
- Shin JI, Lim BJ, Kim PK, Lee JS, Jeong HJ, Kim JH. Effects of cyclosporin A therapy combined with steroids and angiotensin converting enzyme inhibitors on childhood IgA nephropathy. J Korean Med Sci 2010;25:723-7. https://doi.org/10.3346/jkms.2010.25.5.723
- Park JM, Won SC, Shin JI, Yim H, Pai KS. Cyclosporin A therapy for Henoch-Schonlein nephritis with nephrotic-range proteinuria. Pediatr Nephrol 2011;26:411-7. https://doi.org/10.1007/s00467-010-1723-7
- Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Jeong HJ. Henoch-Schonlein purpura nephritis with nephrotic-range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment. Scand J Rheumatol 2005;34:392-5. https://doi.org/10.1080/03009740510026544
- Egido J, Sancho J, Mampaso F, Lopez Trascasa M, Sanchez Crespo M, Blasco R, et al. A possible common pathogenesis of the mesangial IgA glomerulonephritis in patients with Berger's disease and Schonlein-Henoch syndrome. Proc Eur Dial Transplant Assoc 1980;17:660-6.
- Waldo FB. Is Henoch-Schonlein purpura the systemic form of IgA nephropathy? Am J Kidney Dis. 1988;12:373-7.
- Levy M. Familial cases of Berger's disease and anaphylactoid purpura: more frequent than previously thought. Am J Med 1989;87:246-8.
- Montoliu J, Lens XM, Torras A, Revert L. Henoch-Schonlein purpura and IgA nephropathy in father and son. Nephron 1990;54:77-9. https://doi.org/10.1159/000185813
- Thorner PS, Farine M, Arbus GS, Poucell S, Baumal R. IgA nephropathy: Henoch-Schonlein purpura and Berger's disease in one patient. Int J Pediatr Nephrol 1986;7:131-6.
- Chishiki M, Kawasaki Y, Kaneko M, Ushijima Y, Ohara S, Abe Y, et al. A 10-year-old girl with IgA nephropathy who 5 years later developed the characteristic features of Henoch-Schonlein purpura nephritis. Fukushima J Med Sci 2010;56: 157-61. https://doi.org/10.5387/fms.56.157
- Meadow SR, Scott DG. Berger disease: Henoch-Schonlein syndrome without the rash. J Pediatr 1985;106:27-32. https://doi.org/10.1016/S0022-3476(85)80459-5
- Rai A, Nast C, Adler S. Henoch-Schonlein purpura nephritis. J Am Soc Nephrol 1999;10:2637-44.
- D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004;24:179-96. https://doi.org/10.1016/j.semnephrol.2004.01.001
- Jardim HM, Leake J, Risdon RA, Barratt TM, Dillon MJ. Crescentic glomerulonephritis in children. Pediatr Nephrol 1992; 6:231-5. https://doi.org/10.1007/BF00878354
- Niaudet P, Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis. Pediatr Nephrol 1998;12:238-43. https://doi.org/10.1007/s004670050446
- Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Kim PK, et al. Can azathioprine and steroids alter the progression of severe Henoch-Schonlein nephritis in children? Pediatr Nephrol 2005;20:1087-92. https://doi.org/10.1007/s00467-005-1869-x
- Yoshikawa N, Ito H, Sakai T, Takekoshi Y, Honda M, Awazu M, et al. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group. J Am Soc Nephrol 1999;10:101-9.
- Lai KN, Mac-Moune Lai F, Vallance-Owen J. A short-term controlled trial of cyclosporine A in IgA nephropathy. Transplant Proc. 1988;20(3 Suppl 4):297-303.
- Borel JF. Pharmacology of cyclosporine (sandimmune). IV. Pharmacological properties in vivo. Pharmacol Rev 1990;41: 259-371.
- Wiegmann TB, Sharma R, Diederich DA, Savin VJ. In vitro effects of cyclosporine on glomerular function. Am J Med Sci 1990;299:149-52. https://doi.org/10.1097/00000441-199003000-00001
- Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008;14:931-8. https://doi.org/10.1038/nm.1857
- Seikaly MG, Prashner H, Nolde-Hurlbert B, Browne R. Long-term clinical and pathological effects of cyclosporin in children with nephrosis. Pediatr Nephrol 2000;14:214-7. https://doi.org/10.1007/s004670050044
- Iijima K, Hamahira K, Tanaka R, Kobayashi A, Nozu K, Nakamura H, et al. Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephritic syndrome. Kidney Int 2002;61:1801-5. https://doi.org/10.1046/j.1523-1755.2002.00303.x
- Kengne-Wafo S, Massella L, Diomedi-Camassei F, Emma F. Idiopathic membranous nephropathy associated with polycystic kidney disease. Pediatr Nephrol 2010;25:961-3. https://doi.org/10.1007/s00467-009-1398-0
- Hausberg M, Barenbrock M, Hohage H, Müller S, Heidenreich S, Rahn K-H. ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients. Hypertension 1999;33:862-8. https://doi.org/10.1161/01.HYP.33.3.862